Company intelligence / Profile preview

kfgn

Hamburg, Hamburg, Germany6sense.com ↗

Ownership: Private
Development stage: Commercial

Overview

kfgn specializes in the recruitment and implementation of clinical trials as a leading German site management organization. Since its founding in 1995, it has conducted over 700 clinical trials across multiple therapeutic areas. The company operates wholly owned research sites in Hamburg, Schwerin, Hanover, Berlin, Dresden, and Karlsruhe. In 2020 Pratia Inc., part of NEUCA Capital Group, acquired a significant stake with plans for majority ownership. As of March 2023 the company operates under the "Pratia" site network branding but retains its legal entity.

Therapeutic areas: Other
Industry: Contract Research Organization

Partnerships

Pratia Inc./NEUCA Capital Group

Beyond the preview

Go deeper on kfgn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on kfgn.

Explore the full profile